Feedback / Questions
AMB-05X - AmMax
https://www.globenewswire.com/news-release/2022/09/26/2522462/0/en/AmMax-Bio-Provides-Update-on-AMB-05X-Program-for-Tenosynovial-Giant-Cell-Tumor-TGCT.html
Sep 26, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next